Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Minopoli G, de Candia P, Bonetti A, Faraonio R, Zambrano N, Russo T. The beta-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J Biol Chem. 2001 Mar 2;276(9):6545-50. PubMed Abstract, View on AlzSWAN


Corresponding Author: Tommaso Russo
Comments on Paper and Primary News
  Comment by:  Benjamin Wolozin, ARF Advisor (Disclosure)
Permalink
  I recommend this paper

"FE65 is a protein that is associated with APP. The role of this association is poorly understood – as is the role of APP. The observation that APP regulates FE65 function is therefore quite important."

View all comments by Benjamin Wolozin
Comments on Related Papers
  Related Paper: The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink
  I recommend this paper

"This is an interesting paper to show the physiological function of FE65 in cell movement and signal transduction. More related studies are expected to clarify an unknown activity of APP."

View all comments by Hiroshi Mori
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
The GFP-Fe65 and Fe65-HA fusion proteins encoding wt Fe65 obtained by amplification of the rat Fe65 cDNA as described in Faraonio et al. The Fe65 deletion mutants GFP-Fe65D666-711, GFP-Fe65D538-711, GFP-Fe65D1-287, GFP-Fe65D1-253, as well as the fragment corresponding the Fe65 cDNA codons 191-290, were obtained by amplication of the Fe65 cDNA with specific oligonucleotide primers (CEINGE). The Fe65 point mutant C655F cDNA was obtained by using QuickChange Kit (Stratagene). The CMV-Fe65-HA vector expressing wt rat Fe65 tagged with the HA epitope was obtained by cloning in the HindIII site of pRC-CMV (invitrogen). COS-7 cells were cultured in Delbecco's modified Eagle's medium (Life Technologies, Inc.) PC12 cells were cultured in RPMI (Life Technologies, Inc.) supplemented with 10% horse serum, 5% fetal bovine serum, and 1% penicillin/streptomycin mixture. APP was stained with 6E10 or 369 antibodies, using Texas red-conjungated secondary antibodies (Jackson ImmunoResearch Laboratories). Fe65-HA was stained with the anti-HA polyclonal antibody Y-11 (Santa Cruz Biotechnology). For immunoprecipitation, cell extracts were incubated with monoclonal antibody anti-GFP JL8 (Clontech).

FUTURE DIRECTION:
Further experiments are needed to evaluate whether the APP processing by g-secretase could result in the targeting of Fe65 to the nucleus through the cleavage of the transmembrane domain of APP.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad